Gao Pan, Kajiya Mikihito, Motoike Souta, Ikeya Makoto, Yang Jingmei
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of General Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China.
Department of Periodontal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.
Jpn Dent Sci Rev. 2024 Dec;60:95-108. doi: 10.1016/j.jdsr.2024.01.001. Epub 2024 Jan 25.
Guided tissue regeneration (GTR) has been widely used in the periodontal treatment of intrabony and furcation defects for nearly four decades. The treatment outcomes have shown effectiveness in reducing pocket depth, improving attachment gain and bone filling in periodontal tissue. Although applying GTR could reconstruct the periodontal tissue, the surgical indications are relatively narrow, and some complications and race ethic problems bring new challenges. Therefore, it is challenging to achieve a consensus concerning the clinical benefits of GTR. With the appearance of stem cell-based regenerative medicine, mesenchymal stem/stromal cells (MSCs) have been considered a promising cell resource for periodontal regeneration. In this review, we highlight preclinical and clinical periodontal regeneration using MSCs derived from distinct origins, including non-odontogenic and odontogenic tissues and induced pluripotent stem cells, and discuss the transplantation procedures, therapeutic mechanisms, and concerns to evaluate the effectiveness of MSCs.
引导组织再生(GTR)已在骨内和根分叉缺损的牙周治疗中广泛应用了近四十年。治疗结果表明,该方法在减少牙周袋深度、改善附着获得以及牙周组织骨填充方面具有有效性。尽管应用GTR可以重建牙周组织,但其手术适应证相对较窄,并且一些并发症和种族伦理问题带来了新的挑战。因此,就GTR的临床益处达成共识具有挑战性。随着基于干细胞的再生医学的出现,间充质干/基质细胞(MSCs)被认为是牙周再生的一种有前景的细胞资源。在这篇综述中,我们重点介绍了使用源自不同来源(包括非牙源性和牙源性组织以及诱导多能干细胞)的MSCs进行的临床前和临床牙周再生,并讨论了移植程序、治疗机制以及评估MSCs有效性时需要关注的问题。